Skip to Content

ANI 382 150 (Flecainide acetate 150 mg)

Pill imprint ANI 382 150 has been identified as Flecainide acetate 150 mg.

Flecainide is used in the treatment of atrial fibrillation; atrial flutter; supraventricular tachycardia; paroxysmal supraventricular tachycardia; wolff-parkinson-white syndrome (and more), and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Flecainide 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Flecainide acetate
ANI 382 150
150 mg
Elliptical / Oval
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
ANI Pharmaceuticals, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.